ArticleExperimental dermatology2025

Dose Modulation Strategies in Psoriatic Patients: Real-Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose Spacing.

Luca Mastorino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.